Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine

Infection and Immunity

Volumn 70, Issue 2, 2002, Pages 584-590

  Vermont, C L ^a   Van Dijken, H H ^a   Van Limpt, C J P ^a   De Groot, R ^a   Van Alphen, L ^a   Van den Dobbelsteen, G P J M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE;

ANTIBODY AFFINITY; ARTICLE; CHILD; HUMAN; IMMUNITY; MEMBRANE VESICLE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; OUTER MEMBRANE; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY; VACCINATION;

ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; PORINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0036151158     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.2.584-590.2002     Document Type: Article

References (31)

1. Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine
2. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines
3. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
4. Serological use of meningococcal serogroup C conjugate vaccines in the United Kingdom: Reevaluation of correlates of protection
5. Aspects of the molecular structure of IgG subclasses
6. Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins
7. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6
8. Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age
9. Immunogenicity and safety of monovalent p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: Comparison of two vaccination schedules and two vaccine formulations
10. Serum bactericidal activity and isotype distribution of antibodies in toddlers and school children after vaccination with RIVM hexavalent PorA vesicle vaccine
11. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
12. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis
13. The role of pH in modified ELISA procedures used for the estimation of functional antibody affinity
14. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization
15. IgG subclass changes in response to vaccination
16. IgG subclasses in bacterial infections
17. Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: Results of an IUIS/W. H. O. collaborative study
18. nd IUIS/W. H. O. collaborative study
19. Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination
20. Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates
21. The measurement of relative antibody affinity by ELISA using thiocyanate elution
22. Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine
23. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland
24. IgG subclass-associated affinity differences of specific antibodies in humans
25. Production of low-avidity antibody by infants after infection with serogroup B meningococci
26. Antibody avidity determination by ELISA using thiocyanate elution
27. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers
28. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines
29. Measurements of serum IgA and IgG activities to dietary antigens. A prospective study of the diagnostic usefulness in adult coeliac disease
30. Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins
31. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides